Development of Colorimetric Microtiter Plate Assay for Assessment of Antimicrobials against Acanthamoeba

ABSTRACT We have developed and optimized a 96-well microtiter plate assay, based on the reduction of alamarBlue, to assess the efficacies of much needed new antimicrobials against Acanthamoeba species. This assay has been optimized for determination of drug efficacy against two potentially pathogenic species, Acanthamoeba castellanii and Acanthamoeba polyphaga, and has been validated by comparison of their relative susceptibilities to chlorhexidine, a drug widely used to treat Acanthamoeba keratitis. The results demonstrate that the assay is comparable to a manual counting assay and that A. polyphaga is more resistant to chlorhexidine than A. castellanii. Thus, by use of the manual counting assay, 3.125 μM chlorohexidine was almost completely effective against A. castellanii, whereas this concentration was less than 20% effective against A. polyphaga. Similar results were obtained by the alamarBlue assay. The new assay was used to determine the relative susceptibilities of A. castellanii and A. polyphaga to the alkylphosphocholines (APCs) hexadecylphosphocholine (hexadecyl-PC; miltefosine) and octadecylphosphocholine (octadecyl-PC) as well as an alkylgycerolphosphocholine, edelfosine. Both APCs studied were equally effective against A. castellanii, but octadecyl-PC was less effective than hexadecyl-PC against A. polyphaga. Both APCs were more effective than edelfosine against both Acanthamoeba species. A. polyphaga was found to be significantly less susceptible to each of the phosphocholine analogues. The newly described assay offers a number of advantages over those described previously. It is less labor-intensive than previously described assays and is sensitive and rapid, and the results can be read in a nonsubjective manner. As it is based on a standard 96-well, microtiter plate, it is amenable to automation and high throughput.

[1]  K. Hammersmith.  Diagnosis and management of Acanthamoeba keratitis , 2006, Current opinion in ophthalmology.

[2]  D. Seal,et al.  Acanthamoeba keratitis update—incidence, molecular epidemiology and new drugs for treatment , 2003, Eye.

[3]  A. Tomlinson,et al.  Determination of Amoebicidal Activities of Multipurpose Contact Lens Solutions by Using a Most Probable Number Enumeration Technique , 2003, Journal of Clinical Microbiology.

[4]  Y. Yu,et al.  A new rapid and non-radioactive assay for monitoring and determining the proliferation of retinal pigment epithelial cells. , 2003, Korean journal of ophthalmology : KJO.

[5]  S. Croft,et al.  Antiprotozoal activities of phospholipid analogues. , 2003, Molecular and biochemical parasitology.

[6]  J. Maillard.  Bacterial target sites for biocide action , 2002, Journal of applied microbiology.

[7]  K. Seifert,et al.  Cytotoxic Activities of Alkylphosphocholines against Clinical Isolates of Acanthamoeba spp , 2002, Antimicrobial Agents and Chemotherapy.

[8]  H. Yamaguchi,et al.  Usefulness of a colorimetric method for testing antifungal drug susceptibilities of Aspergillus species to voriconazole , 2002, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[9]  G. Visvesvara,et al.  Granulomatous Amebic Encephalitis in a Patient with AIDS: Isolation of Acanthamoeba sp. Group II from Brain Tissue and Successful Treatment with Sulfadiazine and Fluconazole , 2000, Journal of Clinical Microbiology.

[10]  S. Avery,et al.  Flow Cytometry for Determination of the Efficacy of Contact Lens Disinfecting Solutions againstAcanthamoeba spp , 2000, Applied and Environmental Microbiology.

[11]  G. Cabral,et al.  The Increasing Importance of Acanthamoeba Infections1 , 2000 .

[12]  G. Cabral,et al.  The increasing importance of Acanthamoeba infections. , 2000, The Journal of eukaryotic microbiology.

[13]  Robert H. Gilman,et al.  Rapid, Low-Technology MIC Determination with Clinical Mycobacterium tuberculosis Isolates by Using the Microplate Alamar Blue Assay , 1998, Journal of Clinical Microbiology.

[14]  A. D. Russell,et al.  Effects of biocides on Acanthamoeba castellanii as measured by flow cytometry and plaque assay. , 1997, The Journal of antimicrobial chemotherapy.

[15]  L. Collins,et al.  Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium , 1997, Antimicrobial agents and chemotherapy.

[16]  F. Tenover,et al.  Evaluation of Alamar colorimetric broth microdilution susceptibility testing method for staphylococci and enterococci , 1996, Journal of clinical microbiology.

[17]  R. A. Rosenthal,et al.  A quantitative method to evaluate neutralizer toxicity against Acanthamoeba castellanii , 1996, Applied and environmental microbiology.

[18]  S. Revankar,et al.  Copyright � 1995, American Society for Microbiology Use of a Colorimetric System for Yeast Susceptibility Testing , 1994 .

[19]  S. Ahmed,et al.  A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. , 1994, Journal of immunological methods.

[20]  K. Oh,et al.  Quantitative enumeration of acanthamoeba for evaluation of cyst inactivation in contact lens care solutions. , 1991, Investigative ophthalmology & visual science.

[21]  C. Connor,et al.  Effectivity of Contact Lens Disinfection Systems Against Acanthamoeba culbertsoni , 1991, Optometry and vision science : official publication of the American Academy of Optometry.

[22]  G. Visvesvara,et al.  The epidemiology of Acanthamoeba keratitis in the United States. , 1989, American journal of ophthalmology.

[23]  J. Auran,et al.  Acanthamoeba keratitis. A review of the literature. , 1987, Cornea.

[24]  M. B. Moore,et al.  Acanthamoeba keratitis associated with soft contact lenses. , 1985, American journal of ophthalmology.

[25]  C. Culbertson,et al.  Hartmannella (acanthamoeba). Experimental chronic, granulomatous brain infections produced by new isolates of low virulence. , 1966, American journal of clinical pathology.